Resistant Potato Starch for Gulf War Syndrome
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you stop using certain medications, such as prebiotics, probiotics, fiber supplements, antibiotics, anti-diarrheal agents, stool softeners, immunomodulatory medications, and medications that suppress gastric acid, at least 30 days before participating.
What data supports the effectiveness of the treatment Resistant Potato Starch for Gulf War Syndrome?
Research shows that resistant potato starch can influence gut health by altering the microbiome and increasing the production of beneficial short-chain fatty acids, which may have positive effects on gastrointestinal health. Additionally, resistant starch has been used in foods for special medical needs, suggesting potential benefits for various health conditions.12345
Is resistant potato starch safe for human consumption?
How is resistant potato starch treatment different from other treatments for Gulf War Syndrome?
What is the purpose of this trial?
Gulf War Illness (GWI) affects an estimated 25-32% of the over 700,000 coalition troops deployed to the Persian Gulf as part of the First Gulf War. GWI causes a range of pain, fatigue, gastrointestinal, skin, neurologic, and respiratory symptoms. New treatments to reduce GWI-associated morbidity are critically needed. Research suggests a role for the gastrointestinal microbiome in mediating health, including through impacting metabolism and immunity. The disruption of this microbiome plays a role in multiple diseases, and preliminary data suggest that Veterans with GWI have altered gut microbiota. The investigators will evaluate the effectiveness of a dietary fiber prebiotic supplement intervention on improving the quality of life of Veterans with GWI.
Research Team
Nasia Safdar, MD PhD
Principal Investigator
William S. Middleton Memorial Veterans Hospital, Madison, WI
Eligibility Criteria
This trial is for Veterans aged 45-80 with moderate to severe Gulf War Illness (GWI) symptoms, including pain, gastrointestinal issues, and fatigue. Participants must be able to consent, take oral medication, provide samples, and comply with study procedures for the duration of the study. Smokers, heavy drinkers, pregnant women or those planning pregnancy are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either take a RS prebiotic daily for 4 weeks or maintain their usual diet
Follow-up
Participants are monitored for changes in gut microbiome, SCFA concentrations, and quality of life
Treatment Details
Interventions
- Resistant Potato Starch
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor